Application of Economics & Social Psychology to Improve Opioid Prescribing

Status Completed

Clinical Trial Summary

There is a lack of evidence that long-term opioid use offers benefit for noncancer pain and an abundance of evidence of harm. The objective of the R21 pilot phase of the Application of Economics & Social psychology to improve Opioid Prescribing Safety (AESOPS) is to develop and test novel behavioral nudges to encourage adherence to pain and CDC guidelines for opioid prescribing for persons with noncancer pain. Interventions will leverage the electronic health record (EHR) to discourage unnecessary opioid prescribing through the application of "behavioral insights"-empirically-tested social and psychological interventions that affect choice.

Clinical Trial Description

There is a lack of evidence that long-term opioid use offers benefit for noncancer pain and an abundance of evidence of harm. In 2017, the Centers for Disease Control and Prevention (CDC) issued the "CDC Guideline for Prescribing Opioids for Chronic Pain" to encourage safe and effective alternatives to opioids, discontinuation of opioids when patients do not resume normal activities and prudent dosing strategies. However, poor guideline adherence is a general concern and may impede uptake. Our prior studies have used insights from behavioral economics and social psychology to increase guideline adherence. The objective of the R21 pilot phase of the Application of Economics & Social psychology to improve Opioid Prescribing Safety (AESOPS) is to develop and test novel behavioral nudges to encourage adherence to pain and CDC guidelines for opioid prescribing for persons with noncancer pain. At the time of opioid prescribing, clinicians will be prompted with an EHR nudge when the prescribing history for the patient falls into one of the following three mutually exclusive categories: Opioid naïve, At-risk for long term use, or Long-term opioid recipient. The primary outcome is average weekly morphine milligram equivalents (MME) prescribed per-clinician. ;

Study Design

Related Conditions & MeSH terms

Opioid Use, Unspecified

Clinical Trial Details

NCT number	NCT03773484
Study type	Interventional
Source	University of Southern California
Contact
Status	Completed
Phase	N/A
Start date	March 25, 2019
Completion date	November 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06469177` - Patient Centered Post-Op Pain Management Software Tool Interventional Study Verses Standard of Care	N/A
Terminated	`NCT02747875` - Methadone vs. Fentanyl Administration on Postoperative Pain Control in Pediatric Patients Undergoing Cardiac Surgery	N/A
Completed	`NCT02282306` - Phone Interview to Prevent Recurring Opioid Overdoses	N/A
Completed	`NCT02244099` - Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic	N/A
Recruiting	`NCT03923374` - Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
Completed	`NCT04069403` - An Opioid Prescribing Nudge	N/A
Completed	`NCT04155229` - EMR Defaults to Nudge Opioid Prescribing	N/A
Completed	`NCT02299024` - Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter	N/A
Recruiting	`NCT04564729` - Shared Decision Aid for Post-Total Knee Arthroplasty Opioid Prescribing	N/A
Active, not recruiting	`NCT05283980` - Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement	Phase 2/Phase 3
Completed	`NCT04854551` - Opioid Modulation and Neural Reward Activation in Healthy Adults	Phase 1/Phase 2
Recruiting	`NCT06050551` - Pigtail or Chest Tube Placement After Uniportal Video-assisted Thoracoscopic Surgery	N/A
Completed	`NCT04928339` - Pecto-Intercostal Fascial Plane Block Study	Phase 4
Completed	`NCT02653144` - the Analgesic Duration of Dexmedetomidine Compared to Dexamethasone as Adjuncts to Single Shot Interscalene Block	Phase 4
Enrolling by invitation	`NCT05875857` - Patient Utilization of Opioid Destruction Bags in the Post op Period	N/A
Recruiting	`NCT04275258` - Collaborative Opioid Taper After Trauma: Preventing Opioid Misuse and Opioid Use Disorder	N/A
Completed	`NCT04252443` - Nurses' Knowledge and Attitude About Opioids	N/A
Recruiting	`NCT05242081` - Study on Opioid-free Anesthesia Protocol With S-ketamine and Propofol	N/A
Completed	`NCT02431793` - EHR‐Based Medication Complete Communication Strategy to Promote Safe Opioid Use	N/A
Completed	`NCT03959969` - Educational Video on Pain Management and Subsequent Opioid Use After Cesarean Delivery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Application of Economics & Social Psychology to Improve Opioid Prescribing Safety (AESOPS): R21 Pilot Phase — AESOPS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms